As observed with pharmacological inhibitors, the hyperproliferation and resistance to apoptosis of PAH-PASMCs was diminished upon endogenous EZH2 depletion (Figure 2C,D and Figure S2). This evidence concerns the gene EZH2 and pulmonary arterial hypertension.